Page last updated: 2024-08-24

z 424 and transforming growth factor beta

z 424 has been researched along with transforming growth factor beta in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bao, RF; Dong, P; Hu, YP; Jiang, L; Li, HF; Li, ML; Liang, HB; Liu, YB; Lu, W; Shu, YJ; Wang, XA; Wang, Z; Weng, H; Wu, XS; Xiang, SS; Ye, YY; Zhang, F; Zhang, YJ; Zhu, J	1

Other Studies

1 other study(ies) available for z 424 and transforming growth factor beta

Article	Year
MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway. Cell death and differentiation, 2017, Volume: 24, Issue:3 Topics: Aged; Cadherins; Cell Line, Tumor; Cell Proliferation; Disease Progression; Disease-Free Survival; Epithelial-Mesenchymal Transition; Ethanolamines; Female; Gallbladder Neoplasms; Humans; Lymphatic Metastasis; Male; MAP Kinase Signaling System; MicroRNAs; Middle Aged; Prognosis; RNA-Binding Proteins; Survival Rate; Transforming Growth Factor beta	2017

Article

Year

MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway.

Cell death and differentiation, 2017, Volume: 24, Issue:3

Topics: Aged; Cadherins; Cell Line, Tumor; Cell Proliferation; Disease Progression; Disease-Free Survival; Epithelial-Mesenchymal Transition; Ethanolamines; Female; Gallbladder Neoplasms; Humans; Lymphatic Metastasis; Male; MAP Kinase Signaling System; MicroRNAs; Middle Aged; Prognosis; RNA-Binding Proteins; Survival Rate; Transforming Growth Factor beta

2017